VEVYX | WWMCX | VEVYX / WWMCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 12 years | 3 years | - |
Gain YTD | 16.049 | 15.657 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 100000 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.7B | 2.05M | 959,571% |
Annual Yield % from dividends | 1.26 | 1.06 | 119% |
Returns for 1 year | 23.49 | 27.71 | 85% |
Returns for 3 years | 5.01 | N/A | - |
Returns for 5 years | 38.94 | N/A | - |
Returns for 10 years | 60.72 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ACILX | 33.26 | N/A | N/A |
American Century Heritage G | |||
EMECX | 10.96 | N/A | N/A |
Ashmore Emerging Markets Equity C | |||
ASYLX | 16.15 | -0.01 | -0.06% |
AB Select US Long/Short Advisor | |||
LGORX | 24.64 | -0.22 | -0.88% |
Lord Abbett Growth Opportunities R3 | |||
SHPAX | 21.08 | -0.24 | -1.13% |
Saratoga Health & Biotechnology A |